Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2012

Dec 21, 2012

34301_dirs_2012-12-21_e4163614-4f9b-42e5-a9e6-fdae9df54478.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-12-19

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-19 Common Stock P 20000 $2.85 Acquired 108559 Indirect
2012-12-19 Common Stock P 12000 $2.85 Acquired 158101 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 34909 Indirect
Restricted Stock Award (Common Stock) 10000 Direct

Footnotes

F1: Mr. Rickey purchased the shares in connection with a public offering of company shares which closed on December 19, 2012.

F2: These securities are owned by the Dave Rickey and Daughters Foundation.

F3: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust

F4: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.